Bictegravir-Lenacapavir Combo Pill Earns FDA Approval in Suppressed HIV

(MedPage Today) -- The FDA approved the combination of bictegravir and lenacapavir (Bixlenvo) for adults with virologically suppressed HIV-1 infection, Gilead Sciences announced Thursday.
The once-daily single tablet contains 75 mg of the integrase...